SB
TEVA icon

Suntrust Banks’s Teva Pharmaceuticals TEVA Stock Holding History

Suntrust Banks’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$86K Sell
12,527
-1,382
-10% -$10.6K ﹤0.01% 1306
2019
Q2 		$128K Buy
13,909
+2,717
+24% +$32.8K ﹤0.01% 1287
2019
Q1 		$176K Buy
+11,192
New +$197K ﹤0.01% 1238
2018
Q3 		– Sell
-10,521
Closed -$256K – 1309
2018
Q2 		$256K Buy
+10,521
New +$215K ﹤0.01% 1142
2017
Q3 		– Sell
-10,458
Closed -$348K – 1321
2017
Q2 		$348K Sell
10,458
-940
-8% -$29.1K ﹤0.01% 989
2017
Q1 		$366K Sell
11,398
-1,158
-9% -$39.5K ﹤0.01% 953
2016
Q4 		$452K Sell
12,556
-1,635
-12% -$65.3K ﹤0.01% 1042
2016
Q3 		$651K Buy
14,191
+714
+5% +$37.3K ﹤0.01% 871
2016
Q2 		$676K Buy
13,477
+1,131
+9% +$60.2K ﹤0.01% 840
2016
Q1 		$659K Sell
12,346
-121
-1% -$7.1K ﹤0.01% 828
2015
Q4 		$817K Sell
12,467
-422
-3% -$26.1K 0.01% 777
2015
Q3 		$726K Buy
12,889
+493
+4% +$32K ﹤0.01% 734
2015
Q2 		$731K Buy
12,396
+1,705
+16% +$105K ﹤0.01% 739
2015
Q1 		$665K Sell
10,691
-395
-4% -$23K ﹤0.01% 736
2014
Q4 		$636K Sell
11,086
-40,065
-78% -$2.23M ﹤0.01% 737
2014
Q3 		$2.75M Sell
51,151
-2,348
-4% -$124K 0.02% 361
2014
Q2 		$2.8M Sell
53,499
-16,946
-24% -$866K 0.02% 372
2014
Q1 		$3.72M Sell
70,445
-9,861
-12% -$456K 0.01% 515
2013
Q4 		$3.22M Sell
80,306
-84,534
-51% -$3.33M 0.01% 543
2013
Q3 		$6.23M Sell
164,840
-53,005
-24% -$2.07M 0.02% 408
2013
Q2 		$8.54M Buy
+217,845
New +$8.48M 0.04% 366

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Suntrust Banks's TEVA Position: Q3 2019 in Review

Suntrust Banks reduced its Teva Pharmaceuticals (TEVA) stake by 9.9% in Q3 2019, selling an estimated $10.6K and leaving 12,527 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Suntrust Banks first reported a position in TEVA in Q2 2013 and has held it in 21 quarters since. The position peaked at $8.54M in Q2 2013. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Suntrust Banks held 12,527 shares of Teva Pharmaceuticals worth $86K as of Q3 2019.
  • Suntrust Banks sold 1,382 Teva Pharmaceuticals shares in Q3 2019, an estimated $10.6K.
  • Teva Pharmaceuticals made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1306 holding.
  • Suntrust Banks first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • Suntrust Banks's Teva Pharmaceuticals position peaked at $8.54M in Q2 2013.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.